Definitive Healthcare Corp. Class A Common Stock (DH) Stock
NASDAQ · DH
Key stats
- Market cap
- $137.17M
- Price / Earnings ratio
- -0.8x
- EPS (TTM)
- -$1.51
- Volume
- Loading
- 52-week high
- $3.00
- 52-week low
- $0.61
Source: third-party data provider, as of November 13, 2026
Compare with DH
Recent news

Zacks Investment Research
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
DHAugust 10, 2026
Zacks Investment Research
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
DH

MarketBeat
Definitive Healthcare Q2 Earnings Call Highlights
DHAugust 10, 2026
MarketBeat
Definitive Healthcare Q2 Earnings Call Highlights
DH

Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DHJuly 30, 2026
Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DH

Zacks Investment Research
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
DHMay 8, 2026
Zacks Investment Research
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
DH
Technical indicators
- RSI 14
- 68.52
- MACD 12/26/9
- 0.06
- EMA 9 of MACD
- 0.05
- MACD histogram
- 0.01
- SMA 50
- $1.04
- Price above SMA 50
- EMA 50
- $1.04
- Price above EMA 50
- SMA 200
- $1.03
- Price above SMA 200
- EMA 200
- $1.27
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
303M200M100M0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
3B2B841M0
Revenue to Profit
2025$241.5M
Revenue$0.0
Cost of revenue$183.3M
Gross profit$0.0
Operating expenses$-138.9M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

Zacks Investment Research
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
DHAugust 10, 2026
Zacks Investment Research
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
DH

MarketBeat
Definitive Healthcare Q2 Earnings Call Highlights
DHAugust 10, 2026
MarketBeat
Definitive Healthcare Q2 Earnings Call Highlights
DH

Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DHJuly 30, 2026
Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DH

Zacks Investment Research
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
DHMay 8, 2026
Zacks Investment Research
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
DH

Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DHApril 30, 2026
Zacks Investment Research
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
DH

Zacks Investment Research
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates
DHFebruary 27, 2026
Zacks Investment Research
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates
DH

Zacks Investment Research
DH or FFIV: Which Is the Better Value Stock Right Now?
DHFebruary 20, 2025
Zacks Investment Research
DH or FFIV: Which Is the Better Value Stock Right Now?
DH

Zacks Investment Research
DH vs. FFIV: Which Stock Is the Better Value Option?
DHFebruary 3, 2025
Zacks Investment Research
DH vs. FFIV: Which Stock Is the Better Value Option?
DH

Zacks Investment Research
3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates
DHAugust 11, 2023
Zacks Investment Research
3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates
DH

Zacks Investment Research
4 Toxic Stocks That You Should Eliminate From Your Portfolio
DHMarch 27, 2023
Zacks Investment Research
4 Toxic Stocks That You Should Eliminate From Your Portfolio
DH
About Definitive Healthcare Corp. Class A Common Stock
No description available.
SectorHealthcare
IndustryHealth Information Services
Employees678
IPO DateSep 14, 2021
HeadquartersFramingham, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason Ronald Krantz | Founder & Executive Chairman | 1974 |
| Ms. Casey Heller | Chief Financial Officer | 1989 |
| Mr. Jonathan Paris J.D. | Chief Legal Officer & Secretary | 1975 |
| Ms. Marissa Peoples Odell | SVP & Head of Sales | — |
| Ms. Jeannine Lombardi Sheehan | Chief Human Resources Officer | 1974 |
| Ms. Rebecca Marani | Senior VP & Head of Product | — |
| Ms. Sally Slarke | Senior Vice President of Commercial Center of Excellence | — |
| Ms. Tina Hannagan | Chief Commercial Officer | — |
| Mr. Srinivas Attipalli | Senior VP and Head of AI & Data - Product | — |
Fundamentals
Valuation
Price-to-sales ratio0.51
Price-to-book value0.88
Profitability
Return on Equity-88.00%
Return on Assets-28.00%
Return on Sales-66.00%
Gross margin (latest quarter)77.27%
EBITDA$-97.26M
Trading
Average volume403,352
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.52
- MACD 12/26/9
- 0.06
- EMA 9 of MACD
- 0.05
- MACD histogram
- 0.01
- SMA 50
- $1.04
- Price above SMA 50
- EMA 50
- $1.04
- Price above EMA 50
- SMA 200
- $1.03
- Price above SMA 200
- EMA 200
- $1.27
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -33.3 | -4.6 | ||||||||||
| 2022 | -22.3 | +0.1 | +6.5 | -5.9 | -22.3 | +19.9 | +10.6 | -25.5 | -19.4 | -3.1 | -27.4 | -8.4 |
| 2023 | +10.5 | -12.2 | -9.8 | +5.3 | -8.9 | +5.8 | +7.5 | -17.1 | -13.3 | -26.0 | +44.7 | +16.7 |
| 2024 | -16.3 | +10.8 | -10.0 | -13.2 | -23.7 | +4.2 | -27.4 | +18.7 | -3.2 | -5.7 | +13.2 | -13.3 |
| 2025 | +18.0 | -32.0 | +2.1 | +3.0 | +20.4 | +19.3 | -3.7 | +7.8 | +6.6 | -22.2 | -0.7 | +7.9 |
| 2026 | -2.5 | -45.3 | +7.9 | -12.8 | -6.1 | -16.2 | -15.0 | +35.7 | +1.1 | +19.1 | +13.3 |
Compare stocks
Market cap
$137.17M
-
-
-
Price / Earnings ratio
-0.80
-
-
-
Price / Sales ratio
0.51
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
403,352
-
-
-
Earnings per share
$-1.51
-
-
-



